Fibrin presence within aortic valves in patients with aortic stenosis: Association with in vivo thrombin generation and fibrin clot properties

Thrombosis and Haemostasis

Volumn 105, Issue 2, 2011, Pages 254-260

  Natorska, Joanna ^a   Marek, Grzegorz ^b   Hlawaty, Marta ^b   Sadowski, Jerzy ^a   Tracz, Wieslawa ^a   Undas, Anetta ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

Author keywords

Aortic stenosis; Clot structure; Fibrin; Transvalvular gradient

Indexed keywords

D DIMER; FIBRIN; THROMBIN; THROMBOPLASTIN;

ADULT; AGED; AORTA STENOSIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; FEMALE; FIBRIN CLOT; HUMAN; IMMUNOFLUORESCENCE; MALE; PRIORITY JOURNAL;

AGED; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; BLOOD COAGULATION; CALCINOSIS; CHI-SQUARE DISTRIBUTION; FEMALE; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; POLAND; PROTHROMBIN; SEVERITY OF ILLNESS INDEX; THROMBIN; THROMBOPLASTIN;

EID: 79851482952     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-09-0612     Document Type: Article

References (30)

1. Pate GE, Association between aortic stenosis and hypertension. J Heart Valve Dis 2002; 11: 612-614.
2. Ngo MV, Gottdiener JS, Fletcher RD, et al. Smoking and obesity are associated with progression of aortic stenosis. Am J Geriatr Cardiol 2001; 10: 86-90. (Pubitemid 32215684)
3. Mohty D, Pibarot P, Després JP, et al. Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis. Arterioscler Thromb Vasc Biol 2008; 28: 187-193.
4. Novaro GM, Pearce GL, Sprecher DL, et al. Comparison of cardiovascular risk and lipid profiles in patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting. J Heart Valve Dis 2001; 10: 19-24. (Pubitemid 32104459)
5. Mohler ER III. Are atherosclerotic processes involved in aortic-valve calcification? Lancet 2000; 356: 524-525.
6. Yetkin E, Waltenberger J. Molecular and cellular mechanisms of aortic stenosis. Int J Cardiol 2009; 135: 4-13.
7. Otto CM, Kusist J, Reichenbach DD, et al. Characterization of the early lesion of "degenerative" valvular aortic stenosis: histological and immunohistochemical studies. Circulation 1994; 90: 844-853.
8. Ortlepp JR, Pilich M, Schmitz F, et al. Lower serum calcium levels are associated with greater calcium hydroxyapatite deposition in native aortic valves of male patients with severe calcific aortic stenosis. J Heart Valve Dis 2006; 15: 502-508. (Pubitemid 44122679)
9. Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann NY Acad Sci 2001; 936: 11-30. (Pubitemid 32613890)
10. Bini A, Fenoglio JJ, Mesa-Tejada R, et al. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis 1989; 9: 109-121. (Pubitemid 19046097)
11. Sato Y, Hatakeyama K, Yamashita A, et al. Proportion of fibrin and platelets differs in thrombi on ruptured and eroded coronary atherosclerotic plaques in humans. Heart 2005; 91: 526-530. (Pubitemid 40432790)
12. Speiser W, Speiser P, Minar E, et al. Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors. Thromb Res 1990; 59: 77-88. (Pubitemid 20274746)
13. Petkow DP, Hlawaty M, Undas A, et al. Effect of aortic valve stenosis on haemostasis is independent from vascular atherosclerotic burden. Atherosclerosis 2009; 204: 103-108.
14. Natorska J, Marek G, Hlawaty M, et al. Evidence for tissue factor expression in aortic valves in patients with aortic stenosis. Pol Arch Med Wew 2009; 119: 636-642.
15. Bini A, Fenoglio JJ, Sobel J, et al. Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions. Blood 1987; 69: 1038-1045. (Pubitemid 17080921)
16. Teirstein P, Yeager M, Yock PG, et al. Doppler echocardiographic measurement of aortic valve area in aortic stenosis: a noninvasive application of the Gorlin formula. J Am Coll Cardiol 1986; 8: 1059-1065. (Pubitemid 16009090)
17. Lamprecht MR, Sabatini DM, Carpenter AE. CellProfiler: versalite software for automated biological image analysis. BioTechniques 2007; 42: 71-75.
18. Undas A, Zawilska K, Ciesla-Dul M, et al. Altered clot structure/function in patients with idiopathic venous thromboembolism and in their relatives. Blood 2009; 114: 4272-4278.
19. Dong Z, Peng-Yuan Y, Bin Z, et al. Fibrin D-dimer fragments enhance inflammatory responses in macrophages: role in advancing atherosclerosis. Clin Experim Pharmacol Physiol 2007; 34: 185-190.
20. Marechaux S, Corseaux D, Vincentelli A, et al. Identification of tissue factor in experimental aortic valve sclerosis. Cardiovasc Path 2009; 18: 67-76.
21. Breyne J, Juthier F, Croseaux D, et al. Atherosclerotic-like process in aortic stenosis: Activation of the tissue factor-thrombin pathway and potential role through osteopontin alteration. Atherosclerosis 2010; prepub online doi:10.1016/j.atherosclerosis.2010.07.047.
22. Mauriello A, Sangiorgi G, Palmieri G, et al. Hyperfibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks. Circulation 2000; 101: 744-750. (Pubitemid 30100080)
23. Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev 2007; 21: 131-142. (Pubitemid 46541695)
24. Undas A, Szuldrzynski K, Stepien E, et al. Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress. Atherosclerosis 2007; 196: 551-558.
25. Undas A, Kaczmarek P, Sladek K, et al. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease: beneficial effects of simvastatin treatment. Thromb Haemost 2009; 102: 1176-1182.
26. Undas A, Celinska-Lowenhoff M, Lowenhoff T, et al. Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost 2006; 4: 1029-1036.
27. Blombäck B, Carlsson K, Hessel B, et al. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta 1989; 997: 96-110. (Pubitemid 19178601)
28. Goldsmith IRA, Blann AD, Patel RL, et al. Plasma fibrinogen, soluble P-selectin, and von Willebrand factor in aortic valve disease: evidence for abnormal haemorheology, platelet activation, and endothelial dysfunction. Heart 2000; 83: 577-578. (Pubitemid 30316728)
29. Naito N, Stirk CM, Smith EB, et al. Smooth muscle cell outgrowth stimulated by fibrin degradation products: the potential role of fibrin fragment E in restenosis and atherogenesis. Thromb Res 2000; 98: 165-174. (Pubitemid 30122305)
30. Pearson M, Lipowsky HH. Effect of fibrinogen on leukocyte migration and adhesion in postcapillary venules. Microcirculation 2004; 11: 295-306.